The EuroNanoMed3 survey intends to identify the scientific research and innovation priorities in nanomedicine at International, European, national and regional levels by gathering information on national strategies, programmes and initiatives in nanomedicine, as well as funding approaches among nanomedicine actors in Europe and beyond.

The programme owners and programme managing agencies participating in EuroNanoMed3 and others will exchange information on: 

a) national strategies, programmes and initiatives in nanomedicine

and 

b) funding approaches among nanomedicine actors in Europe.

This will help us identify weather the three priorities open within JTC 2017 co-funded call can be adjusted for the additional calls.

In addition to EuroNanoMed partners and funding organisations, other nanomedicine-related initiatives (ESTHER, ETPN, ENATRANS, NanoReg, EAB, SYNAMERA etc.) will be consulted. 

 

Please complete the questionnaire until 03 November 2017.

Thank you very much for your invaluable cooperation. 

 

 

There are 11 large questions in this survey.